Genetic Variant ADH5:c.13-278T>C (chr4-99085494-A-G) – ACMG Classification: Benign (-12 pts)

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000671.4(ADH5):c.13-278T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.777 in 303,480 control chromosomes in the GnomAD database, including 92,642 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 47728 hom., cov: 33)

Exomes 𝑓: 0.77 ( 44914 hom. )

Consequence

ADH5
NM_000671.4 intron

Scores

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.233

Publications

8 publications found

Variant links:

Genes affected

ADH5 (HGNC:253): (alcohol dehydrogenase 5 (class III), chi polypeptide) This gene encodes a member of the alcohol dehydrogenase family. Members of this family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. The encoded protein forms a homodimer. It has virtually no activity for ethanol oxidation, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. This enzyme is an important component of cellular metabolism for the elimination of formaldehyde, a potent irritant and sensitizing agent that causes lacrymation, rhinitis, pharyngitis, and contact dermatitis. The human genome contains several non-transcribed pseudogenes related to this gene. [provided by RefSeq, Oct 2008]

ADH5 Gene-Disease associations (from GenCC):

AMED syndrome, digenic
Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

ADH5 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.91).

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.974 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ADH5	NM_000671.4 link	c.13-278T>C		intron_variant	Intron 1 of 8	ENST00000296412.14	NP_000662.3	P11766Q6IRT1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ADH5	ENST00000296412.14 link	c.13-278T>C		intron_variant	Intron 1 of 8	1	NM_000671.4	ENSP00000296412.8		P11766

Frequencies

GnomAD3 genomes

AF:

0.787

AC:

119691

AN:

152128

Hom.:

47676

Cov.:

show subpopulations

Gnomad AFR

AF:

0.877

Gnomad AMI

AF:

0.673

Gnomad AMR

AF:

0.798

Gnomad ASJ

AF:

0.698

Gnomad EAS

AF:

0.997

Gnomad SAS

AF:

0.884

Gnomad FIN

AF:

0.759

Gnomad MID

AF:

0.772

Gnomad NFE

AF:

0.718

Gnomad OTH

AF:

0.757

GnomAD4 exome

AF:

0.766

AC:

115859

AN:

151234

Hom.:

44914

Cov.:

AF XY:

0.768

AC XY:

59917

AN XY:

78050

show subpopulations

African (AFR)

AF:

0.881

AC:

4452

AN:

5056

American (AMR)

AF:

0.841

AC:

4352

AN:

5174

Ashkenazi Jewish (ASJ)

AF:

0.698

AC:

3954

AN:

5664

East Asian (EAS)

AF:

0.998

AC:

11283

AN:

11302

South Asian (SAS)

AF:

0.876

AC:

7379

AN:

8424

European-Finnish (FIN)

AF:

0.759

AC:

7564

AN:

9966

Middle Eastern (MID)

AF:

0.740

AC:

1778

AN:

2404

European-Non Finnish (NFE)

AF:

0.723

AC:

67431

AN:

93228

Other (OTH)

AF:

0.765

AC:

7666

AN:

10016

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.506

Heterozygous variant carriers

1284

2568

3851

5135

6419

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

GnomAD4 genome

AF:

0.787

AC:

119804

AN:

152246

Hom.:

47728

Cov.:

AF XY:

0.794

AC XY:

59130

AN XY:

74428

show subpopulations

African (AFR)

AF:

0.877

AC:

36468

AN:

41566

American (AMR)

AF:

0.798

AC:

12202

AN:

15290

Ashkenazi Jewish (ASJ)

AF:

0.698

AC:

2423

AN:

3472

East Asian (EAS)

AF:

0.997

AC:

5171

AN:

5186

South Asian (SAS)

AF:

0.884

AC:

4269

AN:

4830

European-Finnish (FIN)

AF:

0.759

AC:

8035

AN:

10590

Middle Eastern (MID)

AF:

0.776

AC:

228

AN:

294

European-Non Finnish (NFE)

AF:

0.718

AC:

48793

AN:

67998

Other (OTH)

AF:

0.760

AC:

1603

AN:

2110

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.503

Heterozygous variant carriers

1279

2558

3836

5115

6394

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.755

Hom.:

78838

Bravo

AF:

0.794

Asia WGS

AF:

0.931

AC:

3235

AN:

3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.91

CADD

Benign

1.1

(source)

DANN

Benign

0.59

PhyloP100

-0.23

PromoterAI

0.0060

Neutral

(source)

Mutation Taster

=100/0

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

chr4-99085494-A-G

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Computational scores

Splicing

Publications

Other links and lift over